AVXL
Anavex Life Sciences Corp
2.40$
+1.7%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +29.6% | +25.8% | -100.0% | – | – | – | – | – | – | – | – | |
| – | +156.1% | +209.8% | -18.3% | +33.4% | +16.6% | -24.2% | +68.8% | +123.3% | -10.9% | -42.3% | +22.4% | |
| – | -65.7% | +128.2% | -16.3% | +35.9% | +14.5% | -22.8% | +68.8% | +123.3% | -6.3% | – | – | |
| – | – | -48.3% | -40.2% | -321.2% | – | -91.0% | -705.9% | – | -53.3% | +9.9% | -253.2% | |
| – | -100.0% | – | -100.0% | – | – | – | +0.0% | +0.0% | -100.0% | – | – | |
| – | -100.0% | – | -100.0% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +3,252.8% | -74.3% | +761.0% | -70.0% | +118.2% | +59.0% | +440.5% | -86.1% | – | – | – | |
| – | -101.0% | -60.6% | – | – | -50.6% | – | – | – | – | – | – | |
| – | +27.9% | -74.4% | +770.5% | -70.4% | +120.3% | +59.4% | +440.5% | -86.1% | +39.3% | -59.6% | -21.2% | |
| – | +16.1% | -176.0% | – | -124.7% | – | – | +1,639.4% | -102.4% | – | -1,109.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.